Article

Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023–24 season

2024-10-30

Abstract excerpt

<h4>Background</h4> The 2023–24 U.S. influenza season was characterized by a predominance of A(H1N1)pdm09 virus circulation with co-circulation of A(H3N2) and B/Victoria viruses. We estimated vaccine effectiveness (VE) in the United States against mild-to-moderate medically attended influenza illness in the 2023–24 season. <h4>Methods</h4> We enrolled outpatients aged ≥8 months with acute respiratory illness in 7...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 12af4569-296d-52c3-bee2-ab12e4efc9bb
DOI: 10.1101/2024.10.29.24316377

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023–24 seasonDOI 10.1101/2024.10.29.24316377Read

Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza SeasonSemantic proximity Read

Influenza vaccine effectiveness against hospitalized SARS-CoV-2 infectionSemantic proximity Read

Influenza vaccine effectiveness in Europe: Results from the 2022–23 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre studySemantic proximity Read

Comparison of Local Influenza Vaccine Effectiveness Using Two MethodsSemantic proximity Read

Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine.Semantic proximity Read

Effectiveness of 2 and 3 mRNA COVID-19 Vaccines Doses against Omicron and Delta-Related Outpatient Illness among Adults, October 2021 – February 2022Semantic proximity Read

Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines.Semantic proximity Read

Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.Semantic proximity Read

Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season.Semantic proximity Read

Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysisSemantic proximity Read

Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE NetworkSemantic proximity Read

Influenza and Influenza Vaccine: A Review.Semantic proximity Read